# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5255544 | F | Antiviral activity against Rift Valley fever virus | Rift Valley fever virus | 1 | organism-based format | Scientific Literature | ||
2. | ALA5255545 | F | Antiviral activity against Tacaribe virus | Mammarenavirus tacaribeense | 1 | organism-based format | Scientific Literature | ||
3. | ALA5255546 | F | Antiviral activity against Human betaherpesvirus 5 | Human betaherpesvirus 5 | 2 | organism-based format | Scientific Literature | ||
4. | ALA5255547 | F | Antiviral activity against influenza A virus H5N1 | Influenza A virus | 1 | organism-based format | Scientific Literature | ||
5. | ALA5255548 | F | Antiviral activity against influenza B virus | Influenza B virus | 1 | organism-based format | Scientific Literature | ||
6. | ALA3607080 | F | Antiviral activity against Yellow fever virus infected in African green monkey Vero cells after 3 days by neutral red dye-based plaque reduction assay | Yellow fever virus | 7 | organism-based format | Scientific Literature | ||
7. | ALA3607081 | F | Antiviral activity against Rift Valley fever virus infected in African green monkey Vero 76 cells after 3 days by neutral red dye-based plaque reduction assay | Rift Valley fever virus | 9 | organism-based format | Scientific Literature | ||
8. | ALA3607083 | F | Antiviral activity against Dengue virus infected in African green monkey Vero cells after 3 days by neutral red dye-based plaque reduction assay | Dengue virus | 8 | organism-based format | Scientific Literature | ||
9. | ALA3607084 | F | Antiviral activity against HCMV infected in HFF after 3 days by neutral red dye-based plaque reduction assay | Human betaherpesvirus 5 | 6 | organism-based format | Scientific Literature | ||
10. | ALA3607181 | F | Antiviral activity against HBV infected in human HepG22.2.15 cells after 3 days by neutral red dye-based plaque reduction assay | Hepatitis B virus | 3 | organism-based format | Scientific Literature | ||
11. | ALA3607182 | F | Antiviral activity against Measles virus infected in African green monkey CV1 cells after 3 days by neutral red dye-based plaque reduction assay | Measles morbillivirus | 6 | organism-based format | Scientific Literature | ||
12. | ALA3607183 | A | Cytotoxicity against African green monkey Vero cells | Chlorocebus sabaeus | 8 | cell-based format | Scientific Literature | ||
13. | ALA3607184 | A | Cytotoxicity against African green monkey Vero 76 cells | Chlorocebus sabaeus | 9 | cell-based format | Scientific Literature | ||
14. | ALA3607187 | A | Cytotoxicity against HFF | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
15. | ALA3607188 | A | Cytotoxicity against MDCK cells | Canis lupus familiaris | 6 | cell-based format | Scientific Literature | ||
16. | ALA3607190 | A | Cytotoxicity against human HepG2(2.2.1) cells | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
17. | ALA3607191 | A | Cytotoxicity against African green monkey CV1 cells | Chlorocebus aethiops | 6 | cell-based format | Scientific Literature | ||
18. | ALA3607192 | F | Selectivity index, ratio of CC50 for African green monkey Vero cells to IC50 for Yellow fever virus | 6 | cell-based format | Scientific Literature | |||
19. | ALA3607196 | F | Selectivity index, ratio of CC50 for HFF to IC50 for HCMV | 5 | assay format | Scientific Literature | |||
20. | ALA3607199 | F | Selectivity index, ratio of CC50 for human HepG2(2.2.1) cells to IC50 for HBV | 2 | assay format | Scientific Literature |